[Research progress of natural killer (NK) cells and the development of coronavirus disease 2019 (COVID-19)]
- PMID: 39442973
[Research progress of natural killer (NK) cells and the development of coronavirus disease 2019 (COVID-19)]
Abstract
Natural killer (NK) cells play an important role in clearing viruses and performing immunomodulation, and they possess innate immunomodulatory functions and acquired immune responses through secreting chemokines and acting in synergy with other natural immune cells. With in-depth studies of coronavirus disease 2019 (COVID-19) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, NK cells have been identified as playing an important role. SARS-CoV-2 infection affects the distribution and effector function of NK cells, and the immune response of NK cells may influence the prognosis of patients with COVID-19. This review summarizes the latest research on the role of NK cells in COVID-19 infection, and discusses their potential as therapeutic agents, aiming to provide insights into the prevention of immune damage caused by SARS-CoV-2.
Similar articles
-
Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.Front Immunol. 2022 Jun 30;13:888248. doi: 10.3389/fimmu.2022.888248. eCollection 2022. Front Immunol. 2022. PMID: 35844604 Free PMC article. Review.
-
SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity.Cell Immunol. 2022 Jan;371:104454. doi: 10.1016/j.cellimm.2021.104454. Epub 2021 Nov 7. Cell Immunol. 2022. PMID: 34773897 Free PMC article.
-
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.Front Immunol. 2020 Jun 23;11:1512. doi: 10.3389/fimmu.2020.01512. eCollection 2020. Front Immunol. 2020. PMID: 32655581 Free PMC article. Review.
-
Natural Killer Cell Dysfunction and Its Role in COVID-19.Int J Mol Sci. 2020 Sep 1;21(17):6351. doi: 10.3390/ijms21176351. Int J Mol Sci. 2020. PMID: 32883007 Free PMC article. Review.
-
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.Front Immunol. 2020 Dec 16;11:610300. doi: 10.3389/fimmu.2020.610300. eCollection 2020. Front Immunol. 2020. PMID: 33391280 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous